# Lisata Therapeutics, Inc.: Form 8-K, filed Jan 27, 2026

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2026-01-27
- Accepted by EDGAR: Jan 27, 2026, 08:27 ET
- Period: 2026-01-27
- Accession: 0000320017-26-000008
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001726000008/clbs-20260127.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001726000008/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001726000008/clbs-20260127.htm

Filed Jan 27, 2026.
Source: SEC EDGAR, the filing index for accession 0000320017-26-000008. Last ingested by Listed: Nov 10, 2026, 04:21 ET. No prices; not investment advice.